Mary L Alpaugh

Title: Mary L Alpaugh: Innovator in Breast Cancer Research

Introduction

Mary L Alpaugh is a prominent inventor based in Los Angeles, CA (US). She has made significant contributions to the field of breast cancer research, holding a total of 3 patents. Her work focuses on developing innovative methods for diagnosing and treating inflammatory breast cancer.

Latest Patents

One of her latest patents is titled "Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use." This invention provides human transplantable inflammatory breast carcinoma xenografts that exhibit unique characteristics. These xenografts can be utilized in experimental models to explore the molecular basis of inflammatory carcinoma. This model aids in identifying molecular targets for therapeutic intervention and assessing the efficacy of various diagnostic and therapeutic agents. Additionally, it describes specific animal models of inflammatory breast cancer and methods for evaluating agents aimed at treating this condition.

Another significant patent is "Methods for identifying molecules whose expression is modulated in inflammatory breast cancer." This invention outlines methods for diagnosing and inhibiting the growth of inflammatory breast cancer metastases in vivo. It provides a comprehensive approach to understanding and combating this aggressive form of cancer.

Career Highlights

Mary L Alpaugh is affiliated with the University of California, where she continues her research and innovation in breast cancer treatment. Her work has garnered attention for its potential impact on therapeutic strategies and patient outcomes.

Collaborations

Throughout her career, Mary has collaborated with notable colleagues, including Sanford H Barsky and James S Tomlinson. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in the field.

Conclusion

Mary L Alpaugh is a dedicated inventor whose work in breast cancer research is paving the way for new diagnostic and therapeutic methods. Her innovative patents reflect her commitment to improving patient care and understanding of inflammatory breast cancer.